GetTopicDetailResponse(id=ac1b988244, topicName=Inovio, introduction=Inovio, content=null, image=null, comments=5, allHits=1168, url=https://h5.medsci.cn/topic?id=9882, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=85971, tagList=[TagDto(tagId=85971, tagName=Inovio)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1649613, encodeId=77cd1649613dc, content=<a href='/topic/show?id=ac1b988244' target=_blank style='color:#2F92EE;'>#Inovio#</a>, objectTitle=Inovio宣布DNA免疫療法治療宮頸癌變創(chuàng)新藥III期臨床成功, objectType=article, longId=208135, objectId=11df20813559, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11df20813559, replyNumber=0, likeNumber=128, createdTime=2022-01-20, rootId=0, userName=appleandpeer, userId=6cc723881515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11df20813559, moduleTitle=Inovio宣布DNA免疫療法治療宮頸癌變創(chuàng)新藥III期臨床成功, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=11df20813559)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1649611, encodeId=82c7164961181, content=<a href='/topic/show?id=ac1b988244' target=_blank style='color:#2F92EE;'>#Inovio#</a>, objectTitle=Inovio的INO-5401聯(lián)合PD-1單抗cemiplimab治療多形膠質(zhì)母細(xì)胞瘤的2期研究，顯示出80％的6個(gè)月無進(jìn)展生存率, objectType=article, longId=182511, objectId=04741825119a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04741825119a, replyNumber=0, likeNumber=70, createdTime=2020-03-31, rootId=0, userName=appleandpeer, userId=6cc723881515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04741825119a, moduleTitle=Inovio的INO-5401聯(lián)合PD-1單抗cemiplimab治療多形膠質(zhì)母細(xì)胞瘤的2期研究，顯示出80％的6個(gè)月無進(jìn)展生存率, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=04741825119a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1649612, encodeId=382f16496127e, content=<a href='/topic/show?id=ac1b988244' target=_blank style='color:#2F92EE;'>#Inovio#</a>, objectTitle=美國疫苗公司Inovio宣布與北京艾棣維欣聯(lián)合在中國推進(jìn)針對新型冠狀病毒的INO-4800疫苗, objectType=article, longId=187177, objectId=a57a18e17763, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a57a18e17763, replyNumber=0, likeNumber=98, createdTime=2020-09-03, rootId=0, userName=appleandpeer, userId=6cc723881515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a57a18e17763, moduleTitle=美國疫苗公司Inovio宣布與北京艾棣維欣聯(lián)合在中國推進(jìn)針對新型冠狀病毒的INO-4800疫苗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a57a18e17763)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1649610, encodeId=04ec164961066, content=<a href='/topic/show?id=ac1b988244' target=_blank style='color:#2F92EE;'>#Inovio#</a>, objectTitle=Inovio宣布采用合成DNA疫苗和PD-1檢查點(diǎn)抑制劑治療后的第二位HPV頭頸癌患者實(shí)現(xiàn)完全緩解, objectType=article, longId=158919, objectId=e6231589192b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6231589192b, replyNumber=0, likeNumber=97, createdTime=2019-03-16, rootId=0, userName=appleandpeer, userId=6cc723881515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6231589192b, moduleTitle=Inovio宣布采用合成DNA疫苗和PD-1檢查點(diǎn)抑制劑治療后的第二位HPV頭頸癌患者實(shí)現(xiàn)完全緩解, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e6231589192b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1649609, encodeId=b3bc1649609eb, content=<a href='/topic/show?id=ac1b988244' target=_blank style='color:#2F92EE;'>#Inovio#</a>, objectTitle=臨床實(shí)驗(yàn)結(jié)果顯示，Inovio公司HIV疫苗免疫響應(yīng)率接近100%, objectType=article, longId=101052, objectId=67b410105255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67b410105255, replyNumber=0, likeNumber=76, createdTime=2017-10-06, rootId=0, userName=appleandpeer, userId=6cc723881515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67b410105255, moduleTitle=臨床實(shí)驗(yàn)結(jié)果顯示，Inovio公司HIV疫苗免疫響應(yīng)率接近100%, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=67b410105255)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
